Please select the option that best describes you:

Would you give adjuvant TDM-1 to a patient with HER2-positive breast cancer s/p NAC with TCHP found to have no residual disease in the breast, but presence of ITCs ypN0(i+) in one axillary lymph node?  



Answer from: Medical Oncologist at Academic Institution
Sign in or Register to read more